 | Christopher Abadi
Medicine, Department of
|
 | Brian G. Abbott
Medicine, Department of
|
 | J. Dawn Abbott
Medicine, Department of
|
 | Muhanned Abu-Hijleh
Medicine, Department of
|
| | J. Gary Abuelo
Medicine, Department of
|
 | Alyn Adrain
Medicine, Department of
|
| | Khaja Ahmed
Medicine, Department of
|
 | Paul Akerman
Medicine, Department of
Surgery, Department of
|
| | Ali Akhtar
Medicine, Department of
|
| | Ahmad Al-Raqqad
Medicine, Department of
|
| | Nicole Alexander
Medicine, Department of
|
| | Tanya Ali
Medicine, Department of
|
 | Jason Aliotta
Medicine, Department of
Dr. Jason Aliotta is an Assistant Professor of Medicine and a clinician in the Division of Pulmonary, Sleep and Critical Care Medicine. He is also a K08-funded investigator in the Division of Hematology/Oncology where his research focuses on the mechanism of bone marrow stem cell production of lung cells in various murine lung injury models. In particular, he has an interest in lung-derived microvesicles as phenotypic modifiers of marrow cells and as mediators of cell-to-cell communication. |
 | Scott Allen
Medicine, Department of
|
| | Kim Amin
Medicine, Department of
|
| | Bret Ancowitz
Medicine, Department of
|
| | Kristin Anderson
Medicine, Department of
|
| | Rex Appenfeller
Medicine, Department of
|
 | James Arrighi
Medicine, Department of
|
 | Andrew Artenstein
Medicine, Department of
|
| | Shadaba Asad
Medicine, Department of
|
| | Daniel Asiedu
Medicine, Department of
|
| | Karen Aspry
Medicine, Department of
|
| | Jeffrey Austerlitz
Medicine, Department of
|
| | Kimberly Babb
Medicine, Department of
|
| | Papa Kaku Badoe
Medicine, Department of
|
| | Katherine Carey Baker
Medicine, Department of
|
| | Marilyn Barbour
Medicine, Department of
|
| | Lucinda Barnard
Medicine, Department of
|
| | Bashar Bash
Medicine, Department of
|
| | Francis Basile Jr
Medicine, Department of
|
| | Kim Basu
Medicine, Department of
|
| | Kerri Batra
Medicine, Department of
|
| | George Bayliss
Medicine, Department of
|
| | Curt Beckwith
Medicine, Department of
Investigation of new and innovative HIV testing programs. This includes HIV testing in non-traditional sites such as correctional facilities, emergency departments, and community-based organizations. This research includes evaluating the implementation of new diagnostic assays such as rapid HIV tests. |
| | Jose Behar
Medicine, Department of
|
| | Vikram Behera
Medicine, Department of
|
| | Geoffrey Berg
Medicine, Department of
|
| | Eric Berger
Medicine, Department of
|
| | Seth Berkley
Medicine, Department of
|
| | David Berz
Medicine, Department of
|
 | Richard Besdine
Medicine, Department of
Richard W. Besdine, MD, has devoted his career to the development and advancement of geriatrics through university-based and public health care policy work for more than 25 years. He has trained more than 100 physicians for academic careers in geriatrics. His research interests include nursing home care, prevention, Medicare quality improvement, and interventions to promote independence in older persons. |
| | Piero Biancani
Medicine, Department of
|
| | Ariel Birnbaum
Medicine, Department of
|
| | Dawna Blake
Medicine, Department of
|
| | Douglas Blecker
Medicine, Department of
|
| | Thomas Bledsoe
Medicine, Department of
Thomas Bledsoe's research interests include medical education, as well as informed consent, models of shared decision making and ethical issues related to end-of-life care. |
| | Praveen Bondalapati
Medicine, Department of
|
| | Alice Bonitati
Medicine, Department of
|
| | Bruno Borenstein
Medicine, Department of
|
| | Andrew Bostom
Medicine, Department of
|
 | Ghada Bourjeily-Habr
Medicine, Department of
Dr. Bourjeily's research focuses on understanding sleep disordered breathing in pregnant women. Some of her research has focused on the pregnancy, obstetric and fetal outcomes of sleep disordered breathing in pregnancy as well as understanding predictors of symptoms of SDB.
Dr Bourjeily has also performed research that focuses on the diagnosis of pulmonary vascular disease in pregnancy focusing on outcomes of diagnostic tests as well as potential adverse effects of such tests. |
| | Sidney Braman
Medicine, Department of
|
| | Jeffrey Bratberg
Medicine, Department of
|
| | Paul Breiding
Medicine, Department of
|
| | Steven Brin
Medicine, Department of
|
 | Deborah Elaine Britt
Medicine, Department of
The overall goal of my research is to advance our understanding of DNA repair, using budding yeast, S. cerevisiae, as a model. We study a protein known as Bcp1 in yeast, or BCCIP in humans. BCCIP acts as a tumor suppressor, promotes cell cycle arrest following DNA damage, and participates in DNA repair. Using molecular and cellular techniques, we intend to define the role of Bcp1 in the DNA damage response and gain insight as to the biological function of this novel and interesting molecule. |
| | Douglas Burtt
Medicine, Department of
|
| | James Butera
Medicine, Department of
|
 | Alfred Buxton
Medicine, Department of
My research focuses on mechanisms underlying ventricular arrhythmias and improving methods to identify patients at risk for sudden cardiac death. |
| | Claudia S. Cabrera
Medicine, Department of
|
| | Nicholas Califano
Medicine, Department of
|
| | Anthony Cannistra
Medicine, Department of
|
| | Lauralyn Cannistra
Medicine, Department of
|
| | Weibiao Cao
Medicine, Department of
Assistant Professor of Medicine and Surgery Weibiao Cao studies the role of a particular enzyme NOX5S in the progression from Barrett esophagus, a condition where cells in the esophagus have been altered by acid reflux, to esophageal adenocarcinoma. His research examines how acid reflux increases the expression of this enzyme, production of hydrogen peroxide (which is known to cause DNA damage), and cell growth in Barrett cells. He hopes to find the potential therapeutic targets to prevent this progression. |
| | Frank Capizzo
Medicine, Department of
|
| | Gerardo Carino
Medicine, Department of
|
| | Robert Carnevale
Medicine, Department of
|
 | Charles Carpenter
Medicine, Department of
Charles Carpenter's research over the past decade has been directed toward two main areas, the optimal treatment of HIV infection in North American women and therapeutic strategies that are effective in the developing world. |
| | E. Jane Carter
Medicine, Department of
My interest focuses on Tuberculosis Program Development and Care Delivery. TB is both the leading killer from a single infectious agent in the world as well as the leading cause of death in patients living with HIV globally. 5ooo die daily. My work focuses both locally is at the RI TB Clinic as well as internationally (primarily in Kenya) to develope community based care programs, promote DOTS expansion,new TB diagnostics for the developing world and coordinated care progams for TB/HIV. |
| | Angelina C. Carvalho
Medicine, Department of
|
| | Leslie Cashel
Medicine, Department of
|
| | Brian Casserly
Medicine, Department of
|
 | Jorge Castillo
Medicine, Department of
Dr. Castillo's main research interests focus on the epidemiology, prognostic factors, diagnosis and therapy of lymphomas and HIV/AIDS-related malignancies. His most recent research efforts are directed to improve the understanding of rare types of lymphoma such as plasmablastic and T-cell lymphomas and their potential association with oncoviruses, such as EBV. He is also interested on outcomes research using meta-analytical methodologies. |
| | John Cava
Medicine, Department of
|
 | Stefano Cazzaniga
Medicine, Department of
|
| | Joyce Chang
Medicine, Department of
|
| | Kimberle Chapin
Pathology and Laboratory Medicine, Department of
Medicine, Department of
|
| | Amos Charles
Medicine, Department of
|
| | Devasis Chatterjee
Medicine, Department of
Resistance to chemotherapy and metastatic tumor growth are major factors thatdirectly lead to the demise of cancer patients. My laboratory studies the regulation of 2 proteins that directly affect tumor cell death (RKIP) and survival (STAT3). We have found that RKIP is a negative regulator of STAT3. We are validating if RKIP is a candidate to be utilized as the basis for molecular-targeted therapeutic strategy for cancer. |
| | Joseph Chazan
Medicine, Department of
|
| | Clinton Chichester
Medicine, Department of
|
| | Bum-Rak Choi
Medicine, Department of
|
| | Pradeep Chopra
Medicine, Department of
|
 | Gaurav Choudhary
Medicine, Department of
The focus of my reseach is to evaluate the mechanisms underlying vascular dysfunction seen in hypoxia and pulmonary hypertension utilizing in vivo, ex vivo, molecular biology and electrohysiological approaches. Specifically, we are interested in understanding the role of natriuretic peptides in hypoxia mediated endothelial dysfunction. |
| | Eirini Christaki
Medicine, Department of
|
| | Fredric Christian
Medicine, Department of
|
| | Ming-Yu Chu
Medicine, Department of
|
| | Sybil Cineas
Medicine, Department of
Pediatrics, Department of
|
| | Jennifer Clarke
Medicine, Department of
Incarcerated populations, women's health, substance abuse and reproductive health. |
| | Jeffrey Clement
Medicine, Department of
|
| | Andrew Cohen
Medicine, Department of
|
| | Evan Cohen
Medicine, Department of
|
| | Reid Coleman
Medicine, Department of
|
| | Bradley Collins
Medicine, Department of
|
| | Maria Constantinou
Medicine, Department of
|
| | John Conte
Medicine, Department of
|
| | Mary Reich Cooper
Medicine, Department of
|
| | Joyce Coppola
Medicine, Department of
|
| | William Corrao
Medicine, Department of
|
 | Dominic Corrigan
Medicine, Department of
|
| | William Corwin
Medicine, Department of
|
| | Christopher Cosgrove
Medicine, Department of
|
| | Richard Cottiero
Medicine, Department of
|
| | Shiavax Cowasji
Medicine, Department of
|
| | Thomas Crain
Medicine, Department of
|
| | Robert Crausman
Medicine, Department of
|
| | Frederick Crisafulli
Medicine, Department of
|
| | Patricia Cristofaro
Medicine, Department of
|
| | James Crowley
Medicine, Department of
|
| | Francis Cummings
Medicine, Department of
|
| | Wilfredo Curioso
Medicine, Department of
|
| | Anne Cushing-Brescia
Medicine, Department of
|
| | Michele Cyr
Medicine, Department of
Administration
|
| | Ehab Daoud
Medicine, Department of
|
| | Kwame Dapaah-afriyie
Medicine, Department of
|
| | James Darnowski
Medicine, Department of
Our research has 2 goals. First, to design, synthesize, and develop new agents for the treatment of human cancer. Second, to determine the differences in signaling processes between cancer cells and normal cells and exploit these differences in cancer prognosis, diagnosis, or treatment. |
| | Robert Davis
Medicine, Department of
|
 | Anne De Groot
Medicine, Department of
Anne De Groot is a nationally recognized expert in epitope-driven vaccines and has been working on TB, HIV (AIDS), HPV (Cervical Cancer) and more recently, smallpox and tularemia vaccines. She has emphasized the development of vaccines that are globally relevant and affordable to the persons at greatest risk of disease. She devotes 80% of her effort to directing the scientific affairs of EpiVax, a biotech company located in Providence, where she is CEO and Chief Scientific Officer. |
| | Vera DePalo
Medicine, Department of
|
 | Silvia Degli Esposti
Medicine, Department of
|
| | Allen Dennison
Medicine, Department of
|
| | David Denofrio
Medicine, Department of
|
| | Thomas Denucci
Medicine, Department of
|
| | Zoltan Derdak
Medicine, Department of
|
| | Hector Derreza
Medicine, Department of
|
| | Clarisse Dexter
Medicine, Department of
|
| | Joseph DiBenedetto
Medicine, Department of
|
 | Joseph Anthony Diaz
Medicine, Department of
Joseph Diaz has the following research interests: cancer control and prevention; language barriers and access to healthcare; patients' use of the internet for medical information; and medical education. |
| | Christy Dibble
Medicine, Department of
|
| | Joseph Dimase
Medicine, Department of
|
| | Robert Dobrzynski
Medicine, Department of
|
| | Walter Donat
Medicine, Department of
|
| | David Dosa
Medicine, Department of
|
| | Thomas Drew
Medicine, Department of
|
| | Jeffrey Drogin
Medicine, Department of
|
 | Karen C. Drumea
Medicine, Department of
The focus of my research is to better understand the role of GA-binding protein (GABP) ets transcription factor in myeloid cell differentiation and maturation and its impact in the development of different types of malignancy (e.g.leukemias). |
| | Christine Duffy
Medicine, Department of
Dr. Duffy's research is focused on issues relevant to cancer survivors, including the primary care and follow-up of cancer survivors, fertility issues related to cancer treatment, and tools to assist cancer survivors in making important decisions. In addition, her research has also focused on how alcohol intake affects reproductive cancers including breast and ovarian. |
 | Kevin Dushay
Medicine, Department of
Dr. Dushay's research interests include: Interstitial Lung Disorders, Advanced Airway Management, ARDS, and Mechanical Ventilation |
 | Lance Dworkin
Medicine, Department of
Lance Dworkin investigates the role of hepatocyte growth factor (HGF) in chronic renal injury, including the effects of HGF on renal fibrosis and scarring, and on renal inflammation, which is an invariable finding in kidneys progressing to end stage renal failure. He is also the study chair for the Cardiovascular Outcomes in Renal Atherosclerotic Lesions (CORAL) trial, a large multicenter randomized clinical trial funded by the National Heart, Lung, and Blood Institute (NHLBI) that is examining the best therapy for patients with hypertension due to atherosclerotic renal vascular disease. |
| | Charles Eil
Medicine, Department of
|
 | Yul Ejnes
Medicine, Department of
|
 | Jonathan Elion
Medicine, Department of
I help to study methods of writing and implementing computer-based Clinical Pathways for guiding medical care. These are flowcharts for assessing and treating illnesses. Formalized guidelines allow for expert care to be made widely available, while allowing for the study of alternate healthcare delivery strategies.
I am also active in the international effort known as Integrating the Healthcare Enterprise ("IHE"), standardizing the way hospital computer systems exchange information. |
| | Ghassan Elkadi
Medicine, Department of
|
| | Peter Eller
Medicine, Department of
|
| | Kristin Ellison
Medicine, Department of
|
| | Rinchen-tzo Emgushov
Medicine, Department of
|
| | Raymond Endreny
Medicine, Department of
|
| | Allan Erickson
Medicine, Department of
|
| | Elkin Estrada
Medicine, Department of
|
 | Faiza Fawaz Estrup
Medicine, Department of
Dean Estrup's recent research interests include the pathogenesis, diagnosis and therapy of gold lung disease in rheumatoid arthritis, and clinical manifestations of human parvovirus infection. She lectures extensively on the rheumatic diseases and especially on osteoporosis, osteoarthritis, the COX-2 inhibitors and the newer therapies for rheumatoid arthritis. |
 | David Ettensohn
Medicine, Department of
|
| | Mark Fagan
Medicine, Department of
|
| | Elaine Fain
Medicine, Department of
|
 | Loren Fast
Medicine, Department of
The encounter with white blood cells from another individual often occurs in pregnancy, transfusion, and transplantation and can both negatively and positively impact the recipient's immune system. The focus of the laboratory is to characterize the regulatory mechanisms involved in this encounter and especially the effects on killer cells. A second area of interest is the role of the enzymes produced by killer cells in life threatening conditions generated in response to infection and trauma. |
 | Edward Feller
Medicine, Department of
Community Health, Department of
Director, Division of Gastroenterology ( Miriam Hosp. ); Co-director, Community Health clerkship (Brown Medical School). Clinical interests include inflammatory pancreatic disease and viral hepatitis in underserved populations. Research focuses on medical student teaching ; fostering student involvement in scientific writing for publication and presentation at scientific meetings, including 64 student presentations at regional or national meetings from 2002-2009. |
| | Mary Anne Fenton
Medicine, Department of
|
| | Steven Fera
Medicine, Department of
|
| | Edward Filardo
Medicine, Department of
Estrogen promotes growth of the mammary gland and certain tumors that arise from this tissue. Its effects are largely manifested by estrogen receptors, ERa and ERb, which bind estrogen and promote biochemical signals associated with cellular proliferation. ER-independent estrogen action has particular relevance for breast tumors that fail to express ERs (about one-third of all breast tumors). We have identified a role for GPR30, an orphan receptor in estrogen action. Studies in my lab focus on understanding its mechanism of action and its influence on breast tumor cell behavior. |
| | Bruce Fischer
Medicine, Department of
|
| | Staci Fischer
Medicine, Department of
My primary research interests lie in infections complicating solid organ transplantation as well as infections of implanted devices such as ventricular assist devices and orthopedic prostheses. |
 | Timothy Flanigan
Medicine, Department of
Timothy P. Flanigan has spearheaded a program of modified, directly-observed therapy for HIV treatment for individuals who are marginalized and would otherwise not receive the benefit of new combination HIV treatments. A pilot program for active substance abusers to provide community based treatment strategies has been cited nationally. This work has received funding through an RO1 grant from the National Institutes of Health (NIH). Pilot programs to extend these community based therapies for pregnant women and persons leaving prison have begun. |
| | Mary Flynn
Medicine, Department of
In general, my research interest is in how diet can be used to improve health and body weight. I currently have a grant that compares the diet recommended by the National Cancer Institute to a plant-based olive oil diet that I have put together based upon foods that the literature suggests will improve health. I am studying women diagnosed wtih invasive breast cancer after the age of 50. |
| | Glenn Fort
Medicine, Department of
|
| | David Fortunato
Medicine, Department of
|
| | A. Raymond Frackelton
Medicine, Department of
Pathology and Laboratory Medicine, Department of
|
| | Nancy Freeman
Medicine, Department of
|
| | David Fried
Medicine, Department of
|
 | Peter Friedmann
Medicine, Department of
Community Health, Department of
1) Organization of treatment services, esp. linkage to comprehensive services.
2) Role of primary care in diagnosis and management of substance abuse
3) Sleep disorders and relapse to alcoholism
4) Integration of correctional and community services for addicted offenders. |
| | Ana Tuya Fulton
Medicine, Department of
|
| | Joseph Gaeta
Medicine, Department of
|
| | Melissa Gaitanis
Medicine, Department of
Enrolling and retaining high risk women in HIV prevention/vaccine trials. |
| | Rebekah Gardner
Medicine, Department of
|
| | Jennifer Gartman
Medicine, Department of
|
| | Bethany Gentilesco
Medicine, Department of
|
| | Peter Gibson
Medicine, Department of
|
 | David Gifford
Medicine, Department of
Community Health, Department of
Quality of Care
Nursing Homes
Quality Improvement
Public Reporting
|
| | Deidre Gifford
Medicine, Department of
|
| | Fizza S. Gillani
Medicine, Department of
With my strong background in the combined fields of Econometrics and systems analysis, my primary interests include project and data design, data management, and systems analyses. My current research focuses on optimizing information systems utilized by faculty and students affiliated with the medical school as well as by various local and national agencies. Given my past research experience in developing countries, I hope to continue this work at an international level. |
| | Ronald Gilman
Medicine, Department of
|
| | Irving Gilson
Medicine, Department of
|
| | Michael Gilson
Medicine, Department of
|
 | Reginald Gohh
Medicine, Department of
I am interested in learning why some immunosuppressive drugs are more effective in preventing rejection in certain patient populations compared to others, with a specific interest in the diabetic population. I am also involved in studies which look at the most effective immunosuppressive drug combinations in preventing rejection and long-term outcomes. Other studies focus on the the effect of kidney transplantion on the quality of life of these unfortunate patients. |
 | Rujun Gong
Medicine, Department of
Renal inflammation is a common process driving the progression of chronic kidney disease (CKD). We have shown that hepatocyte growth factor (HGF) retards CKD progression, suppressing both glomerular and tubulointerstital injury through its potent anti-inflammatory effect. Currently, we are trying to delineate the precise molecular mechanisms for this anti-inflammatory action by applying morphologic, physiologic, and molecular techniques to cultured cells and animal models with kidney diseases. |
 | Geetha Gopalakrishnan
Medicine, Department of
The focus of Gopalakrishnan's research is on HIV-related endocrinopathies as well as bone and mineral metabolism. She has participated in numerous studies evaluating risk factors for and treatment of osteoporosis, osteopenia, and hyperparathyroidism. She is currently coordinating studies to evaluate the bone complications of HIV-infection and treatment regimens. She also is developing trials on the prevention and treatment of osteoporosis in HIV infected individuals. Collaborating with the International Health Institute at Brown University and the Y.R. Gaitonde Center for AIDS Research and Education in Chennai, India, Gopalakrishnan is involved in studies evaluating endocrine complications of HIV.
|
| | Pamina Gorbach
Medicine, Department of
|
| | Paul Gordon
Medicine, Department of
|
| | Walter Goula
Medicine, Department of
|
| | Stefan Gravenstein
Medicine, Department of
|
 | Traci Green
Medicine, Department of
|
| | David Greenblatt
Medicine, Department of
|
| | Neil Greenspan
Medicine, Department of
|
 | Stephen Gregory
Medicine, Department of
Currently, our laboratory is conducting experiments using mouse models to determine the factors that cause inflammation and protective immunity to bacteria that infect the liver and/or lungs. |
| | Iulia Grillo
Medicine, Department of
|
| | Katie Grinnell
Medicine, Department of
|
| | Nicholas Grumbach
Medicine, Department of
Pediatrics, Department of
|
| | Ned Gutman
Medicine, Department of
|
| | Levis Guzman
Medicine, Department of
|
| | Fadallah Habr
Medicine, Department of
|
| | Suhdong Hahn
Medicine, Department of
|
| | Harald Hall
Medicine, Department of
|
| | Geoffrey Hamilton
Medicine, Department of
|
| | Milton William Hamolsky
Medicine, Department of
|
| | Sajeev Handa
Medicine, Department of
|
| | Karen Harnett
Medicine, Department of
Our research examines the mechanisms mediating contraction of the smooth muscle in the esophagus and Lower Esophageal Sphincter (LES). Disorders of esophageal motor function and LES competence, for instance gastroesophageal reflux disease, affect more than one in ten adults over 40 and one in four adults over 60 years of age. We investigate the inflammation-associated changes in the signaling mechanisms mediating esophageal contraction that occur with gastroesophageal reflux disease. |
 | Elizabeth Harrington
Medicine, Department of
My research focuses on characterizing intracellular signaling mechanisms which regulate endothelial cell functions and/or responses to environmental cues. Vascular injury has been implicated in the pathogenesis of disorders such as sepsis and acute respiratory distress syndrome (ARDS). Identification of molecules key in regulating endothelial cell functions may lead to therapeutic strategies for controlling vascular tissue damage and enhancing repair. |
| | Abigail Harrison
Population Studies and Training Center
Medicine, Department of
|
| | Pamela Harrop
Medicine, Department of
|
| | Joseph Harwell
Medicine, Department of
HIV in women, prevention of mother-to-child transmission of HIV, clinical care of HIV in resource-poor settings, sexually transmitted infections |
| | Linda Hassan
Medicine, Department of
|
| | Meghan Hayes
Medicine, Department of
|
 | Jiman He
Medicine, Department of
|
| | Christine Herbert
Medicine, Department of
|
| | David Herec
Medicine, Department of
|
| | Debra Herman
Medicine, Department of
|
| | Melvin Hershkowitz
Medicine, Department of
|
| | Lauri Hicks
Medicine, Department of
|
| | Nicholas Hill
Medicine, Department of
|
 | Douglas Hixson
Medicine, Department of
Ongoing research aims to identify the molecular events necessary to turn a normal cell into a cancer cell. We have shown that restoration of an adhesion protein known as CEACAM suppresses the growth of cancer cells. Current efforts are aimed at exploiting this ability for treatment. In addition, we have identified a stem cell population in normal liver that is targeted by cancer-causing chemicals. Current research focuses on determining defects that prevent maturation of precancerous stem cells. |
| | Mary Hohenhaus
Medicine, Department of
|
| | Robert Hopkins
Medicine, Department of
|
| | Frederic Hoppin
Medicine, Department of
Molecular Pharmacology, Physiology and Biotechnology, Department of
|
| | Andrew Hordes
Medicine, Department of
|
| | Jeffrey Horowitz
Medicine, Department of
|
| | Harold Milton Horwitz
Medicine, Department of
|
| | Adriana Hosu
Medicine, Department of
|
| | Guang Hu
Medicine, Department of
|
| | Susie Lee Hu
Medicine, Department of
Division of Renal Diseases, Department of Internal Medicine
|
| | Marianne Hurley
Medicine, Department of
|
| | Syed Hussain
Medicine, Department of
|
| | Michael Hyder
Medicine, Department of
|
| | Edward Iannuccilli
Medicine, Department of
|
| | Sadia Iftikhar
Medicine, Department of
|
| | Henry Izeman
Medicine, Department of
|
| | Ivor M. Jackson
Medicine, Department of
|
| | Mark Jacobs
Medicine, Department of
|
| | Matthew Jankowich
Medicine, Department of
Dr. Jankowich is conducting clinical and epidemiologic research focused on the interactions between lung function and systemic vascular disease. Individuals with impaired lung function have an elevated risk of cardiovascular events. Dr. Jankowich's work is focused on improving understanding of the factors associated with increased cardiovascular risk in the setting of lung function impairment. He also studies the advanced lung disease combined pulmonary fibrosis and emphysema. |
 | Gregory Jay
Emergency Medicine, Dept. of
Medicine, Department of
Engineering, Division of
Dr. Jay has investigated the lubricating properties of synovial fluid and what role it may play in degenerative joint diseases. He confirmed that lubricin is a mucinous glycoprotein and showed that the glycosylations on this molecule provide for a lower coefficient of friction between both biological and non-biological rubbing surfaces. He is interested in more immediate translational studies in the areas of automated pulsus paradoxus monitoring in emergency medicine. He has developed and/or tested a portable hyperbaric chamber system, bedside co-oximetry, and other novel devices. |
| | Thomas Jean
Medicine, Department of
|
| | Jennifer Jeremiah
Medicine, Department of
|
| | Hitesh Jindal
Medicine, Department of
|
| | Michael Johnson
Medicine, Department of
|
| | Plakyil Joseph
Medicine, Department of
|
| | Djuro Josic
Medicine, Department of
Using his expertise in the separation and identification of biopolymers, particularly membrane and plasma proteins, Djuro Josic's current work is focused on the development methods of isolating cells and organelles, proteomic and glycomic characterization of plasma membrane proteins from liver and hepatocellular carcinoma, and the identification of biomarkers for cancer and other diseases. He is also studying changes after aristolochic acid poisoning in order to understand kidney failure that sometimes ends with urothelial cancer caused by this environmental agent. |
| | Charles Kahn
Medicine, Department of
|
| | Sewell Kahn
Medicine, Department of
|
| | Brett Kalmowitz
Medicine, Department of
|
 | Rami Kantor
Medicine, Department of
Rami Kantor's research focuses on the evolution of HIV drug resistance to antiretroviral medications, which jeopardizes treatment success. The research incorporates bioinformatics, sequence and phylogenetic analyses, databases and data management, as well as basic laboratory research. More specifically, he is studying the evolution of drug resistance in HIV variants that predominate in resource-limited settings and in developing countries, where the majority of the AIDS epidemic is located. |
| | Stephen Kaplan
Medicine, Department of
|
| | Peter Karczmar
Medicine, Department of
|
| | Gary Katzman
Medicine, Department of
|
| | Donald Kaufman
Medicine, Department of
|
| | William Kaye
Surgery, Department of
Medicine, Department of
|
| | Edward Keating
Medicine, Department of
|
| | Steven Kempner
Medicine, Department of
|
| | Razib Khaund
Medicine, Department of
|
| | Elias Khawam
Medicine, Department of
|
| | Humera Khurshid
Medicine, Department of
|
 | Susan M. Kiene
Medicine, Department of
Dr. Susan M. Kiene studies behaviors that put individuals at risk for HIV/AIDS and methods for preventing HIV transmission. Dr. Kiene's research program in rural Uganda (the Salawo Uganda--Brown Collaboration) aims to develop effective and sustainable methods in the public health care sector to empower individuals to change their behavior to protect themselves from HIV or to prevent transmitting HIV to un-infected others. |
 | Miran Kim
Medicine, Department of
Our research focuses on to define the molecular mechanisms of hepatocarcinogenesis. Currently we are investigating how the Wnt signaling pathway is involved in the development and/or progression of hepatocellular carcinoma (HCC). HCC is one of most common and devastating malignant disease worldwide. Neverthless, the molecular pathogenesis of HCC are largely unknown. Therefore, our effort to understand the effect of this pathway on development of HCC should yield new avenues for HCC treatment. |
| | Brian Andrew Kimble
Medicine, Department of
|
| | Boyd King
Medicine, Department of
|
| | Malcolm Kirk
Medicine, Department of
|
| | William Kirkpatrick
Medicine, Department of
|
| | David Kitzes
Medicine, Department of
|
| | Jack Klie
Medicine, Department of
|
 | James Klinger
Medicine, Department of
|
| | Robert Knisley
Medicine, Department of
|
| | Erna Kojic
Medicine, Department of
Dr. Kojic's current research is on HPV/HIV co-infection in women. She is currently studying anogenital HPV infections and related diseases of HIV in women and is chairing an AIDS Clinical Trial Group (ACTG) study on the safety of the Quadrivalent HPV vaccine in HIV infected women. This pilot research study seeks to assess the safety and immunogenicity of the HPV vaccine among HIV infected women with different CD4 counts and viral loads. |
| | Gideon Koren
Medicine, Department of
Gideon Koren's research focuses on the regulation of expression voltage-gated potassium channels and mechanisms of sudden death. One of his current research projects involves rabbits expressing dominant negative transgenes that suppress the expression of repolarization currents in the heart. Transmitters are implanted to monitor the heart rhythm to help determine when and why they might die of ventricular arrhythmias. In addition, Koren's group is studying the transcriptional regulation and trafficking of these channels. |
| | Kenneth Korr
Medicine, Department of
|
| | Thomas Krahn
Medicine, Department of
|
| | Naomi Kramer
Medicine, Department of
|
| | Dennis Krauss
Medicine, Department of
|
| | N. Kumarasamy
Medicine, Department of
|
 | Awewura Kwara
Medicine, Department of
Awewura Kwara's current research focus is the development of molecular and clinical models to identify and predict pharmacokinetic drug-to-drug interactions between antiretroviral and antituberculous agents. His work also investigates the effect of genetic polymorphisms of drug-metabolizing enzymes on treatment outcomes. |
| | John Ladetto
Medicine, Department of
|
| | Edward Lally
Medicine, Department of
Major areas of research interests are in the clinical arena.
1. Connective tissue disease including scleroderma and systemic lupus erythematosus (SLE, Lupus). I've had a long interest in SLE and Lupus both in terms of patient care as well as doing clinical studies of patients with these disorders.
2. The other is in osteoarthritis. I've been a consultant on the Osteoarthritis Initiative (Based at Memorial Hospital). I've been collaborating with a group in Orthopedic Surgery at Brown to develop an Osteoarthritis Center, which would be involved in the diagnosis, treatment, and research of osteoarthritis. |
 | Michelle Lally
Medicine, Department of
Michelle Lally serves as the Director of the HIV Vaccine Clinical Trials Unit for Brown University/The Miriam Hospital; her primary research interests include HIV prevention, testing, and vaccine development. Her attention also focuses on health care disparity, access to HIV and other STD education, testing, and treatment, and the representation of women and minorities in clinical trials. She has also worked extensively in the area of rapid HIV testing and its potential community applications. |
| | Jon Lambrecht
Medicine, Department of
|
| | Kerry Laplante
Medicine, Department of
|
| | Jerome Larkin
Medicine, Department of
|
| | Steven Larosa
Medicine, Department of
|
 | Lucia Larson
Medicine, Department of
Research interest in medical problems in pregnancy including thromboembolic disease, preeclampsia, and cardiac disorders. |
 | Marc Laufgraben
Medicine, Department of
|
| | George Lee
Medicine, Department of
|
| | Louis Leone
Medicine, Department of
|
| | William Levin
Medicine, Department of
|
| | Daniel Levine
Medicine, Department of
|
| | Paul David Levinson
Medicine, Department of
|
 | Mitchell Levy
Medicine, Department of
1) End of life care in the intensive care unit (ICU): developing interventions for measuring and improving the quality of care at the end of life in the ICU
2)Sepsis: Improving the quality of care that patients with sepsis (severe infections) receive in the ICU
3) Changing clinical practice: developing models that help bedside clinicians utilize the most recent research results to improve patient care
4) Outcomes reporting: Using databases associated with computerized ICU systems to measure and report outcomes of critically ill patients |
 | David Lewis
Community Health, Department of
Medicine, Department of
My academic interest has been in the evaluation of addiction prevention and treatment programs and screening and brief intervention for substance abuse in all clinic practices. For some time I was involved in testing new developments in treatment procedures, including the introduction of new psychopharmalogical agents. More recently, I worked on projects to evaluate the effectiveness of health professional education and the adoption of evidence-based policies. |
 | Ji Su Li
Medicine, Department of
Hepatitis B (HBV) and C (HCV) viruses are the major etiological agents of primary hepatocellular carcinoma (HCC). Both viruses frequently cause chronic hepatitis leading to persistent liver injury, liver cirrhosis, and eventually HCC. The molecular mechanisms underlying the viral pathogenesis and carcinogenesis are poorly understood. Our current research projects focus on identification of host proteins required for the early stage of HBV life cycle, and viral-host interaction in HCV pathogenesis. |
| | Lei-Shi Li
Medicine, Department of
|
| | Jonah Licht
Medicine, Department of
|
| | Warren Licht
Medicine, Department of
|
| | Sheldon Lidofsky
Medicine, Department of
|
 | Yow-Pin Lim
Medicine, Department of
My research focuses on the role of serine protease inhibitors in inflammation, sepsis, and cancer metastasis. Inter-alpha inhibitors (IaI) are a family of complex proteins known to inhibit serine proteases such as trypsin, elastase, and plasmin. Significant decrease of IaI levels is found in septic patients and the levels correlate inversely with disease severity and mortality. The long term goal is to develop IaI as a useful theranostic marker and a therapeutic agent in sepsis and cancer. |
| | Nancy Littell
Medicine, Department of
|
| | Gongxin Liu
Medicine, Department of
|
| | Na Liu
Medicine, Department of
|
| | Vito Longobardi
Medicine, Department of
|
 | John Lonks
Medicine, Department of
|
| | Peem Lorvidhaya
Medicine, Department of
|
| | Mariam Louis
Medicine, Department of
|
 | Qing Lu
Medicine, Department of
Vascular endothelial cells, a monolayer lining the inner wall of blood vessels, play a crucial role in human health and disease. Pulmonary endothelium dysfunction and injury cause various devastating lung diseases. The focus of Dr. Lu's study is to understand the molecular mechanism(s) underlying pulmonary endothelium dysfunction and injury in response to biochemical stimulations. It is hope that her study will inform possible therapeutic strategies for lung diseases. |
| | Ivana Lukacova-Zib
Medicine, Department of
|
| | Christopher Luttmann
Medicine, Department of
|
| | Michael Macko
Medicine, Department of
|
 | David Maclean
Medicine, Department of
|
| | Samuel Maghuyop
Medicine, Department of
|
| | Michael Maher
Medicine, Department of
|
| | Rosemary Maher
Medicine, Department of
|
| | Samir Makarious
Medicine, Department of
|
| | Tariq Malik
Medicine, Department of
|
| | Steven Mallozzi
Medicine, Department of
|
| | Shafiq Mamdani
Medicine, Department of
|
| | Rosario Manalo
Medicine, Department of
|
| | James Manis
Medicine, Department of
|
| | Fadi Mansourati
Medicine, Department of
|
| | Vincent Marcaccio 3rd
Medicine, Department of
|
| | David Marcoux
Medicine, Department of
|
| | Peter Margolis
Medicine, Department of
|
| | Edward Martin
Medicine, Department of
|
| | Donnah Mathews
Medicine, Department of
|
| | Jennifer Maude
Medicine, Department of
|
 | Kenneth Hugh Mayer
Medicine, Department of
Kenneth H. Mayer has studied the natural history of HIV and the biological and prevention aspects of HIV acquisition and transmission since the start of epidemic. He led research teams that documented the first cases of HIV in New England. He studied the heterosexual spread of HIV and viral HIV expression in the male and female genital tracts. He led prevention research studies, including behavioral interventions, microbicides, and vaccine trials. He is also the principal investigator of an international training grant funded by the Fogarty International Center of the National Institutes of Health (NIH). |
 | Steven McCloy
Medicine, Department of
international health
needs assessment in Guatemala, Central America
work injuries |
| | F. Dennis McCool
Medicine, Department of
My research centers on respiratory muscle physiology and the mechanics of breathing. In general, I address clinical questions related to respiratory muscle function and dysfunction and my research integrates principles of basic science with clinical medicine. Specifically I 1) apply principles of skeletal muscle function to determine mechanisms that set respiratory muscle endurance, 2) evaluate diaphragm dysfunction in varied disease states including respiratory failure, 3) developed ultrasound as a technique to non-invasively assess diaphragm function and 4) use chest wall displacements to make non-invasive measurements of ventilation. |
| | Charles McCoy
Medicine, Department of
|
| | George McKendall
Medicine, Department of
|
| | Sharon McKenzie
Medicine, Department of
|
| | Lynn McNicoll
Medicine, Department of
Delirium
Hospitalized Care for older persons
Intensive care for older persons
Quality improvement
Falls
Pressure Ulcers |
| | Richard Mead
Medicine, Department of
|
| | Antone Medeiros
Medicine, Department of
|
| | Ildiko Medve
Medicine, Department of
|
| | Anthony Mega
Medicine, Department of
|
| | Joseph Vincent Meharg
Medicine, Department of
|
 | Niharika Mehta
Medicine, Department of
|
| | A. Sattar Memon
Medicine, Department of
|
 | Ulrike Mende
Medicine, Department of
Ulrike Mende is interested in the functional role of G proteins (GTP-binding proteins) and their regulators (Regulators of G protein Signaling) in the heart. They are crucial for the transmission of signals from the cell surface to the inside. Changes in their amount or function often lead to compromised cardiac function and disease, such as hypertrophy and failure. Our goal is to delineate the underlying molecular mechanisms and devise new therapeutic strategies. |
| | Robert Meringolo
Medicine, Department of
|
 | Leonard Mermel
Medicine, Department of
My research interests are in the pathogenesis, epidemiology, and prevention of hospital-acquired infections, especially, but not limited to, infections associated with intravascular catheters and those due to multi-drug resistant pathogens. |
| | Nanda Methuku
Medicine, Department of
|
| | Jacqueline Michaud
Medicine, Department of
|
| | Dennis Mikolich
Medicine, Department of
|
 | Maria Mileno
Medicine, Department of
Please contact Dr. Mileno at Maria_Mileno@brown.edu |
 | Margaret Miller
Medicine, Department of
Dr. Miller's research interests include cardiovascular risk in women with pregnancy complications and the effectiveness of interpregnancy care. |
| | Richard Millman
Medicine, Department of
My research interests over the years have centered on obstructive sleep apnea. I am currently involved in several research studies regarding this disorder in diabetics, pregnant women and overweight individuals undergoing weight loss surgery. I am also interested in the impact of noise on sleep in hospital settings. In adddition I am involved in several projects involving drug abusers currently on methadone to keep them from using illicit drugs again. Our research involves the impact of lack of sleep on relapse rate. |
| | David Mills
Medicine, Department of
A primary interest of our laboratory is the role of hepatic progenitor cells (oval cells in rodents) in liver carcinogenesis. These progenitor cells are located within the ductules of the hepatic biliary tree and have been implicated in liver repair, regeneration and carcinogenesis. A second area of interest examines cell adhesion molecule interactions with hepatic immune cells in response to liver injury. |
| | John Miskovsky
Medicine, Department of
|
| | Brian Montague
Medicine, Department of
|
| | Terri Montague
Medicine, Department of
|
| | Nancy Moore
Medicine, Department of
|
| | Louis Moran
Medicine, Department of
|
| | Blas Moreno
Medicine, Department of
|
 | Steven Moss
Medicine, Department of
Steven Moss studies the role of the bacterium, Helicobacter pylori, in gastric (stomach) cancer.
H. pylori is found commonly in the human stomach and is highly adapted for infection lasting decades. Its presence is associated with peptic ulcer disease, chronic gastritis and gastric adenocarcinoma, but how this bacterium causes disease is not well understood. We examine interactions between H. pylori and the human gastric epithelium which may be relevant to the pathogenesis of these diseases. Our current focus is on the effects of H. pylori in modulating gastric epithelial cell cycle control, via decreasing the expression of gastric p27(kip1), an important cell cycle regulatory and tumor suppressor protein. |
| | Albert Most
Medicine, Department of
|
| | Anne Moulton
Medicine, Department of
|
 | John Murphy
Medicine, Department of
Dr. Murphy studies preventive health interventions, and metrics for functional status in older populations, and has collaborated with the American Academy of Family Physicians to enhance family practice training nationwide. Murphy helped create and implement a curriculum in geriatrics for primary care residencies throughout the United States, and has worked to develop postgraduate primary care training programs in China, Jordan and Russia. |
| | John Murphy
Medicine, Department of
|
| | John Murphy
Medicine, Department of
|
| | James Myers
Medicine, Department of
|
| | Ahmed Nadeem
Medicine, Department of
|
| | Kiran Nakkala
Medicine, Department of
|
 | Aman Nanda
Medicine, Department of
Aman Nanda, an assistant professor in medicine, is interested in the home health care related issues of home bound older persons. Also interested in health care issues related to nursing home care in older persons and dizziness in older persons. |
| | Marguerite Neill
Medicine, Department of
|
| | Lina Nemchenok
Medicine, Department of
|
| | Nishant Nerella
Medicine, Department of
|
 | Linda Nici
Medicine, Department of
|
| | Adam Niedelman
Medicine, Department of
|
| | Ank Nijhawan
Medicine, Department of
|
 | Eduardo A. Nillni
Medicine, Department of
Severe obesity is associated with dramatic changes in body fat content, particularly subcutaneous or intra-abdominal (visceral) fat that results in cardiovascular disease and type 2 diabetes. Obesity has reached epidemic proportions worldwide and affects 1 in 3 Americans. A better understanding of the causes of obesity to further develop new anti-obesity drugs lies in uncovering the molecular and physiologic mechanisms that regulate appetite, satiety, and energy balance. The main focus in my laboratory is to study the biology of different hypothalamic neuropeptides involved in the regulation of energy balance and thyroid function. |
| | Thomas Noonan
Medicine, Department of
|
 | Amy Nunn
Medicine, Department of
Amy Nunn conducts research on HIV testing, HIV risk behaviors and how to best link people living with HIV/AIDS to treatment and care services in the United States and abroad. She has also conducted research on politics and economics affect access to essential medicines in developing countries. |
| | John O'Bell
Medicine, Department of
|
| | J. Michael O'Connell
Medicine, Department of
|
| | Thomas O'Toole
Medicine, Department of
|
| | Laura Ofstead
Medicine, Department of
|
| | G. Richard Olds Sr.
Medicine, Department of
|
| | Jeanne Oliva
Medicine, Department of
|
| | Susan Oliverio
Medicine, Department of
|
 | Steven Opal
Medicine, Department of
Our primary research interest is to understand how the human immune system recognizes invasive bacterial infections. We study toxins and invasion genes from bacterial pathogens with the long term goal of developing better treatments and new vaccines against severe bacterial infections. |
| | Francisco Amado Mejia Ortiz
Medicine, Department of
|
| | Bai-Chuan Pan
Medicine, Department of
|
| | Maoyin Pang
Medicine, Department of
|
| | Alfred Parisi
Medicine, Department of
|
| | Joel Park
Medicine, Department of
|
| | Michael Passero
Medicine, Department of
|
| | Eleni Patrozou
Medicine, Department of
|
| | Vincent Pera
Medicine, Department of
|
| | Arthur Phillips
Medicine, Department of
|
| | Paul Pirraglia
Medicine, Department of
Dr. Pirraglia researches the impact of depression and anxiety on chronic medical illness. His current work includes examining antidepressant prescribing using large databases, developing a collaborative care intervention for depression and anxiety in veterans with chronic obstructive pulmonary disease, and investigating the impact of chronic medical illness on patients with bipolar disorder. |
| | Ewa Piszczek
Medicine, Department of
|
| | Angela Plette
Medicine, Department of
|
| | Jose R. Polanco
Medicine, Department of
|
| | Michael Pomerantz
Medicine, Department of
|
| | Aurora Pop-Vicas
Medicine, Department of
|
| | Athena Poppas
Medicine, Department of
|
 | Roy Poses
Medicine, Department of
|
| | Michael Poshkus
Medicine, Department of
|
| | Susan Potter
Medicine, Department of
|
 | Raymond Powrie
Medicine, Department of
|
| | Kittichai Promrat
Medicine, Department of
I am interested in the natural history and therapy of chronic liver diseases, in particular hepatitis B, C and nonalcoholic steatohepatitis (NASH). My research efforts involve the roles of insulin resistance and obesity in the pathogenesis of NASH. I am also interested in various aspects of clinical and translational research in chronic viral hepatitis and nonalcoholic fatty liver disease. |
| | Peter Quesenberry
Medicine, Department of
|
| | Daniel Quirk
Medicine, Department of
|
| | Joseph Rabatin
Medicine, Department of
|
| | Herbert Rakatansky
Medicine, Department of
|
 | Bharat Ramratnam
Medicine, Department of
Our focus is on defining the key cellular components that impact the replication of viruses such as HIV-1, herpes simplex virus (HSV) one and two, influenza, and hepatitis B/C. We use a variety of genetic and proteonomic techniques to identify host factors that impact viral replication, some of which may constitute novel targets for pharmacotherapy. |
| | Roger Raymond
Medicine, Department of
|
| | Vishram Rege
Medicine, Department of
|
| | Ramona Rhodes
Medicine, Department of
|
| | Iole Ribizzi-Akhtar
Medicine, Department of
|
| | Anthony Ricci
Medicine, Department of
|
| | Harlan Rich
Medicine, Department of
|
 | Josiah Rich
Medicine, Department of
Josiah Rich has a number of research interests including: the overlap between infectious diseases and addiction; HIV/AIDS, Hepatitis B and C, sexually transmitted diseases; incarcerated populations; access to addiction treatment; and HIV in the Dominican Republic and Russia. |
| | Katherine Richman
Medicine, Department of
|
| | Renee Ridzon
Medicine, Department of
|
| | Raymon Riley
Medicine, Department of
|
| | Rachel Roach
Medicine, Department of
|
| | Barbara Roberts
Medicine, Department of
|
| | James Robertson
Medicine, Department of
|
| | Karim Roder
Medicine, Department of
|
| | Marina Rodriguez
Medicine, Department of
|
| | Rodrigo Luis Romulo
Medicine, Department of
|
 | Karen Rosene Montella
Medicine, Department of
Obstetrics and Gynecology, Dept. of
|
 | Cynthia Rosengard
Medicine, Department of
Cynthia Rosengard, Ph.D., M.P.H., is an associate professor of obstetrics & gynecology and medicine at the Warren Alpert Medical School of Brown University and Women & Infants Hospital. Her research interests focus on understanding adolescents' sexual decision-making within different types of romantic/sexual relationships, as well as HIV/STD prevention interventions. Her work incorporates traditional quantitative evaluation, as well as qualitative data collection and analysis. |
 | Sharon Rounds
Medicine, Department of
Pathology and Laboratory Medicine, Department of
Sharon Rounds is interested in mechanisms of lung vascular injury in conditions causing pulmonary hypertension and acute lung injury. Her work focuses on the way in which endothelial cells of the lung circulation are injured. Current research focuses on the role of small GTPase post-translational processing in modulation of lung vascular permeability and apoptosis.
She is also interested in chronic obstructive pulmonary disease and factors that impair compliance with therapy. Another clinical research interest is pulmonary hypertension. |
| | Richard Ruggieri
Medicine, Department of
|
| | Lorna Russell
Medicine, Department of
|
| | J. Mark Ryan
Medicine, Department of
|
| | Hani Sabbour
Medicine, Department of
|
| | Ara Sadaniantz
Medicine, Department of
|
| | Immad Sadiq
Medicine, Department of
|
| | Howard Safran
Medicine, Department of
|
| | Gisele Saliba
Medicine, Department of
|
 | Adrian Salmon
Medicine, Department of
|
| | Fadi Samaan
Medicine, Department of
|
| | Sundaresan Sambandam
Medicine, Department of
|
| | Benjamin Sapers
Medicine, Department of
|
| | Jay Schachne
Medicine, Department of
|
| | Fred Jay Schiffman
Medicine, Department of
|
| | Mark Schleinitz
Medicine, Department of
My research centers around decision-analysis and cost-effectiveness analysis applied to a number of clinical domains. These include anti-platelet therapy for the prevention of cardiovascular events, policies to reduce the rate of hospitalization for long-term nursing home residents, emerging breast cancer screening modalities, including ultrasound and MRI, and using utility theory as a tool for the evaluation of breast cancer treatment disparities. |
| | Franklin Schneider
Medicine, Department of
|
| | John Schneider
Medicine, Department of
|
| | Larry Schoenfeld
Medicine, Department of
|
| | David Schreiber
Medicine, Department of
|
 | Howard Schulman
Medicine, Department of
|
| | Harry Schwartz
Medicine, Department of
|
| | Ronald Schwartz
Medicine, Department of
|
| | Stuart Schwartz
Medicine, Department of
|
| | Jack Schwartzwald
Medicine, Department of
|
| | Robert Schwengel
Medicine, Department of
|
| | H. Denman Scott
Community Health, Department of
Medicine, Department of
|
| | Stephen Scott
Medicine, Department of
|
| | Steven Sepe
Medicine, Department of
|
| | Thomas Sepe
Medicine, Department of
|
| | Kurush Setna
Medicine, Department of
|
 | Robert Settipane
Medicine, Department of
|
| | Russell Settipane
Medicine, Department of
|
 | Samir Shah
Medicine, Department of
|
| | Barry Sharaf
Medicine, Department of
|
 | Katherine Sharkey
Medicine, Department of
Katie Sharkey's research focuses on sleep and circadian rhythms, particularly in relation to mood regulation, psychiatry, and women's health. Her current projects include a study of sleep apnea in pregnant women in collaboration with Dr. Ghada Bourjeily, a study of phase-delayed circadian rhythms in college students with Dr. Mary Carskadon, a study of sleep in patients in methadone maintenance treatment with Dr. Michael Stein, and a pilot study of sleep and mood regulation in postpartum women. |
| | Satish Sharma
Medicine, Department of
|
| | Parviz Shavandy
Medicine, Department of
|
| | Douglas Shemin
Medicine, Department of
|
| | Charles Sherman
Medicine, Department of
|
| | Victor Shin
Medicine, Department of
|
| | Hatem Shoukeir
Medicine, Department of
|
| | Richard Shulman
Medicine, Department of
|
| | Michael Siclari
Medicine, Department of
|
| | William Sikov
Medicine, Department of
|
| | Fredric Joel Silverblatt
Medicine, Department of
|
| | Mark Siskind
Medicine, Department of
|
| | Mitchel Sklar
Medicine, Department of
|
| | Jean Smith
Medicine, Department of
|
| | Jeanette Smith
Medicine, Department of
|
 | Robert Smith
Medicine, Department of
Robert Smith's current projects are investigating mechanisms of the cellular actions of the hormone insulin and the closely-related insulin-like growth factors (IGFs). These include studies on recently identified proteins in the insulin and IGF pathways that may have roles in causing diabetes, neurodegenerative disease, and disturbed metabolism in critical illness. Clinical research projects focus on the effectiveness and importance of glucose control in diabetes and on causes of human growth disorders. |
| | W. Tyler Smith
Medicine, Department of
|
| | Suniti Solomon
Medicine, Department of
|
| | Jay Sorgman
Medicine, Department of
|
| | Jeremy Spector
Medicine, Department of
|
| | Joel Spellun
Medicine, Department of
|
| | Joseph Spinale
Medicine, Department of
|
| | Vladimir Stamoran
Medicine, Department of
|
| | Michael Stanchina
Medicine, Department of
|
| | Michael Stein
Medicine, Department of
1) HIV prevention studies
2) Drug use and HIV disease
3) Brief intervention in primary care settings
4) Drug abuse treatment outcomes
5) Needle exchange and methadone program intervention 5)Smoking cessation interventions
6) Marijuana use interventions for adolescents and young adults |
| | Philip Stockwell
Medicine, Department of
|
| | John Stoukides
Medicine, Department of
|
| | Michelle Stozek
Medicine, Department of
|
| | Rochelle Strenger
Medicine, Department of
|
| | Edward Stulik
Medicine, Department of
|
| | James Sullivan
Medicine, Department of
|
| | Eleanor Summerhill
Medicine, Department of
|
| | Joseph Sweeney
Medicine, Department of
Pathology and Laboratory Medicine, Department of
|
| | Dominick Tammaro
Medicine, Department of
|
| | Karen Tashima
Medicine, Department of
|
| | Lynn Taylor
Medicine, Department of
Lynn E. Taylor, M.D., is an HIV specialist focusing on HIV and viral hepatitis coinfection. Her research to date involves extending HCV treatment to persons with HIV and co-existing psychiatric and substance disorders. |
| | Joseph Terlato
Medicine, Department of
|
| | Anthony Testa
Medicine, Department of
|
| | Arumugam Thanumalaya
Medicine, Department of
|
| | Walter Thayer
Medicine, Department of
|
| | Deepak Thiagarajan
Medicine, Department of
|
| | Anthony Thomas
Medicine, Department of
|
| | Edward Thomas
Medicine, Department of
|
| | Valerie Thomas
Medicine, Department of
|
 | Nancy Thompson
Pathology and Laboratory Medicine, Department of
Medicine, Department of
Administration
Nancy L. Thompson, Ph.D., is Associate Dean for Graduate and Postdoctoral Studies in the Division of Biology & Medicine at Brown University, Professor of Medicine and Pathology & Laboratory Medicine (Research). Previous active research interests included cancer/injury related gene expression and molecular biomarkers. Dr. Thompson has been the PI of 2 Department of Education GAANN pre-doctoral training grants and is currently Co-PI of an Initiative to Maximize Student Development grant from NIH. |
| | William Thompson
Surgery, Department of
Medicine, Department of
|
| | Michael Thursby
Medicine, Department of
|
| | Peter Tilkemeier
Medicine, Department of
Dr. Tilkemeier's research is primarily focused on the applications of imaging in patient care as well as predicting quality. His interests in the field of cardiac rehabilitation have focused on behavioral modification and the benefits of cardiac rehabilitation from a behavioral model including depression, anxiety and compliance with a long-term cardiac rehabilitation program. His other interests focus on the application of standards in imaging techniques, particularly nuclear cardiology. |
 | Iris Tong
Medicine, Department of
|
 | Shuping Tong
Medicine, Department of
We are interested in establishing the impact of hepatitis B virus genotypes and naturally occurring mutations on viral genome replication, protein expression (core protein and e antigen), and virus particle release. It is well documented that certain mutations and some viral genotypes are closely associated with the development of liver cancer, but the molecular mechanisms remain unknown. We use molecular approaches to address this important medical problem. |
| | Philip Torgan
Medicine, Department of
|
 | Amal Trivedi
Community Health, Department of
Medicine, Department of
|
| | Caroline Troise
Medicine, Department of
|
| | Joseph Tucci
Medicine, Department of
|
| | Paul E. Van Zuiden
Medicine, Department of
|
| | Sreekala Vasudevan
Medicine, Department of
|
| | Todd Viccione
Medicine, Department of
|
 | Jack Wands
Medicine, Department of
Jack Wands directs the Liver Research Center, a newly constructed 13,000-sq. ft. facility that emphasizes studies relating to the molecular biology of liver diseases. |
| | Christine Wanke
Medicine, Department of
|
 | Nicholas Ward
Medicine, Department of
Prior research has focused on mediators of inflammation in Acute Lung Injury and Sepsis and mechanical ventilation of patients with ARDS. I continue to work in clinical trial on sepsis and other ICU infections.
Current research focuses on ethics, rationing, and intensive care unit utilization. |
| | Marilyn Weigner
Medicine, Department of
|
| | Barbara Weil
Medicine, Department of
|
| | Alan Weitberg
Medicine, Department of
|
| | Mary Beth Welesko
Medicine, Department of
|
 | Joel Weltman
Medicine, Department of
Influenza bioinformatics. |
| | Jane Wen
Medicine, Department of
|
| | Patrick Weyer
Medicine, Department of
|
| | Edward Wheeler Jr
Medicine, Department of
|
| | David Williams
Medicine, Department of
David Williams's research interests are focused in two areas. The first is acute ischemic heart disease that includes acute coronary syndromes and acute myocardial infarction (heart attack). The second interest is in percutaneous coronary intervention, primarily non-surgical treatment of coronary artery and structural heart disease. |
| | Eric Winer
Medicine, Department of
|
 | Edward Wing
Medicine, Department of
Edward Wing's research interests are focused on the immune host defenses against intracellular pathogens such as Listeria monocytogenes and Mycobacterium tuberculosis. He also has a strong clinical interest in infectious diseases, HIV, and international health. |
| | Sabrina Witherby
Medicine, Department of
|
| | Edward Wittels
Medicine, Department of
|
| | Karen Woolfall-Quinn
Medicine, Department of
|
| | Tony Wu
Medicine, Department of
|
 | Wen-Chih Wu
Medicine, Department of
The focus of my research is on the prevention of cardiovascular diseases and to improve patient outcomes through improvement of quality of medical care |
 | Haiyan Xu
Medicine, Department of
|
| | Joseph Yammine
Medicine, Department of
|
| | Angelito Yango
Medicine, Department of
Angelito Yango's research work focuses on clinical transplantation with emphasis on acute and chronic rejection as well as enhancing quality of life after kidney transplantation. Dr. Yango has recently introduced a program for protocol renal biopsies to monitor early stages of rejection in kidney transplant recipients. Dr. Yango is also investigating the role of hepatocyte growth factor and GSK3b in the pathogenesis of chronic allograft nephropathy. |
| | Ronald Yankee
Medicine, Department of
|
| | David Yoburn
Medicine, Department of
|
| | Paul Yodice
Medicine, Department of
|
| | Najam Zaidi
Medicine, Department of
|
| | Nickolas Zaller
Medicine, Department of
Current research interests include: the overlap of infectious diseases, illicit substance use, and incarceration; social and behavioral interventions for substance use; epidemiology of HIV and viral hepatitis infection; health disparities and structural determinants in accessing substance use and mental health treatment services. |
| | Peng Zhang
Medicine, Department of
|
| | Shougang Zhuang
Medicine, Department of
|
| | Bernard Zimmermann
Medicine, Department of
|
| | Stephen Zinner
Medicine, Department of
|
| | John Zwetchkenbaum
Medicine, Department of
|
